Literature DB >> 26311424

The Role of Berberine in the Multi-Target Treatment of Senile Dementia.

Min Huang, Siyan Chen, Yubin Liang, Yi Guo1.   

Abstract

Dementia is an acquired progressive cognitive dysfunction, affecting the content of consciousness rather than the level of consciousness. Most dementia is senile dementia, accounting for the majority of dementia. The most important and common form of senile dementia is refractory dementia, which includes Alzheimer's disease (AD) and vascular dementia (VD). Due to the diversity and uncertainty of the pathogenic mechanism of VD and AD, no significantly effective drug currently exists. Berberine is a natural isoquinoline alkaloid extracted from Coptis chinensis that has a wide range of pharmacological effects. studies in recent years have also found that berberine can additionally treat senile dementia by affecting neurotransmitter, anti-oxidative stress, metabolism and other multi-target pathways. Multi-target treatment of senile dementia by berberine is a potential avenue of study for senile dementia treatment.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26311424     DOI: 10.2174/1568026615666150827095433

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  13 in total

1.  Identification of the first noncompetitive SARM1 inhibitors.

Authors:  Heather S Loring; Sangram S Parelkar; Santanu Mondal; Paul R Thompson
Journal:  Bioorg Med Chem       Date:  2020-07-17       Impact factor: 3.641

Review 2.  Central and Peripheral Metabolic Defects Contribute to the Pathogenesis of Alzheimer's Disease: Targeting Mitochondria for Diagnosis and Prevention.

Authors:  Yunhua Peng; Peipei Gao; Le Shi; Lei Chen; Jiankang Liu; Jiangang Long
Journal:  Antioxid Redox Signal       Date:  2020-03-16       Impact factor: 8.401

3.  [Berberine inhibits erastin-induced ferroptosis of mouse hippocampal neuronal cells possibly by activating the Nrf2-HO-1/GPX4 pathway].

Authors:  Q Huang; D Ji; X Tian; L Ma; X Sun
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2022-06-20

4.  Berberine ameliorates rats model of combined Alzheimer's disease and type 2 diabetes mellitus via the suppression of endoplasmic reticulum stress.

Authors:  Wei-Ting Xuan; Han Wang; Peng Zhou; Ting Ye; Hua-Wu Gao; Shu Ye; Jing-Hui Wang; Meng-Lian Chen; Hang Song; Yan Wang; Biao Cai
Journal:  3 Biotech       Date:  2020-07-29       Impact factor: 2.406

5.  Synergic Effects of Berberine and Curcumin on Improving Cognitive Function in an Alzheimer's Disease Mouse Model.

Authors:  Lin Lin; Cheng Li; Deyi Zhang; Mingxiang Yuan; Chun-Hai Chen; Maoquan Li
Journal:  Neurochem Res       Date:  2020-02-21       Impact factor: 3.996

6.  Fuzheng Quxie Decoction Ameliorates Learning and Memory Impairment in SAMP8 Mice by Decreasing Tau Hyperphosphorylation.

Authors:  Yang Yang; Xingxing Jia; Jianchao Feng; Zhiyong Wang; Yu Cao; Jiangang Liu; Hao Li
Journal:  Evid Based Complement Alternat Med       Date:  2017-12-20       Impact factor: 2.629

7.  Jiao-Tai-Wan Improves Cognitive Dysfunctions through Cholinergic Pathway in Scopolamine-Treated Mice.

Authors:  Xin-Chen Wang; Yu-Min Xu; Hong-Ying Li; Chun-Ying Wu; Ting-Ting Xu; Na-Chuan Luo; Shi-Jie Zhang; Qi Wang; Shi-Jian Quan
Journal:  Biomed Res Int       Date:  2018-06-27       Impact factor: 3.411

8.  Berberine Improves Cognitive Impairment by Simultaneously Impacting Cerebral Blood Flow and β-Amyloid Accumulation in an APP/tau/PS1 Mouse Model of Alzheimer's Disease.

Authors:  Chenghui Ye; Yubin Liang; Ying Chen; Yu Xiong; Yingfang She; Xiaochun Zhong; Hongda Chen; Min Huang
Journal:  Cells       Date:  2021-05-11       Impact factor: 6.600

Review 9.  Role of berberine in Alzheimer's disease.

Authors:  Zhiyou Cai; Chuanling Wang; Wenming Yang
Journal:  Neuropsychiatr Dis Treat       Date:  2016-10-03       Impact factor: 2.570

10.  Mitochondria play an important role in the cell proliferation suppressing activity of berberine.

Authors:  Xiao-Jin Yan; Xuan Yu; Xin-Pei Wang; Jing-Fei Jiang; Zhi-Yi Yuan; Xi Lu; Fan Lei; Dong-Ming Xing
Journal:  Sci Rep       Date:  2017-02-09       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.